Correction: Quantification of overnight urinary gonadotropin excretion predicts imminent puberty in girls: a semi-longitudinal study (Hormones, (2023), 10.1007/s42000-023-00499-7)
Abstract
In this article, at panel C in Figure 2, the word “U-FSH” in the title of the graph should be changed to “total U-LH”. In Results section, under the title “Predictability of onset of puberty based on cross sectional data”, the text “(Figs. 1A and 2A)” should be added to the end of the first sentence. In Results section, under the title “Predictability of imminent menarche based on cross sectional data”, the text “(Figs. 2C and 3A)” should be added to the end of the first sentence. The original article has been corrected. © 2023, The Author(s).
Collections
Related items
Showing items related by title, author, creator and subject.
-
RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study
Ryu, Hyunjin; Park, Hayne C.; Oh, Yun Kyu; Sangadi, Irene; Wong, Annette; Mei, Changlin; Ahn, Curie (Bmj Publishing Group, 2020)Introduction Patients with autosomal dominant polycystic kidney disease (ADPKD) reach end-stage renal disease in their fifth decade on average. For effective treatment and early intervention, identifying subgroups with ... -
Open, prospective, Multi-Center, Two-Part study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronate-BONCURE: Results of Turkish sub-study
Eskiyurt, Nurten; İrdesel, Jale; Sepici, Vesile; Uğurlu, Hatice; Kirazlı, Yeşim; Ardıç, Füsun; Öncel, Hakan (2012)Amaç: BONCURE (Mevcut Bisfosfonat Kullanıcıları İçin Bonviva Bölgesel Avrupa Çalışması) ile daha önce günlük veya haftalık alendronat veya risendronat alan postmenopozal osteoporozu olan kadınlarda aylık ibandronat için ...